Cystic fibrosis telemedicine in the era of COVID-19
- PMID: 35224457
- PMCID: PMC8867557
- DOI: 10.1093/jamiaopen/ooac005
Cystic fibrosis telemedicine in the era of COVID-19
Abstract
The coronavirus disease 2019 pandemic has resulted in large-scale changes to incorporate telemedicine for the delivery of care. People with cystic fibrosis (CF) have care considerations that pose challenges to telemedicine; they include frequent visits for pulmonary disease progression, medication management, and evaluation by a multidisciplinary team of providers. We share our center's experience with video visits replacing in-person clinic evaluation, using quality improvement strategies to create a replicable workflow. Key considerations include incorporation of the multidisciplinary team into the visit, limitations of remote delivery of care, as well as patient and staff perceptions of this care model. Results revealed that video visits were convenient, efficacious, and comparable to in-person visits, with interest for its continued incorporation into the traditional CF care model.
Keywords: coronavirus; cystic fibrosis; pandemic; pulmonary disease; telemedicine.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association.
Figures
References
-
- Spoonhower KA, Davis PB.. Epidemiology of cystic fibrosis. Clin Chest Med 2016; 37 (1): 1–8. - PubMed
-
- Cystic Fibrosis Foundation. Understanding changes in life expectancy. www.cff.org/Research/Researcher-Resources/Patient-Registry/Understanding.... Accessed November 2020.
-
- Wendekier C, Wendekier-Raybuck K.. Cystic fibrosis. Nurse Pract 2021; 46 (9): 48–55. - PubMed
-
- Corriveau S, Sykes J, Stephenson AL.. Cystic fibrosis survival: the changing epidemiology. Curr Opin Pulm Med 2018; 24 (6): 574–8. - PubMed
-
- Smyth AR, Bell SC, Bojcin S, et al. European cystic fibrosis society standards of care: best practice guidelines. J Cyst Fibros 2014; 13 (1): S23–S42. - PubMed
LinkOut - more resources
Full Text Sources